Clinical Trial Update: Radiofrequency Ablation Versus Stereotactic Radiotherapy in Colorectal Liver Metastases [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing radiofrequency ablation to stereotactic radiotherapy for colorectal cancer with liver metastases has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Snippet

Sponsor: University of Aarhus | Conditions: Colorectal Carcinoma, Liver Metastases | Phase 3 | Status: TERMINATED